Page last updated: 2024-09-04

cyc 202 and Graft vs Host Disease

cyc 202 has been researched along with Graft vs Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boussiotis, V; Kim, Js; Li, L; Pihan, G; Wang, H1
Grant, S1

Other Studies

2 other study(ies) available for cyc 202 and Graft vs Host Disease

ArticleYear
The cyclin dependent kinase inhibitor (R)-roscovitine prevents alloreactive T cell clonal expansion and protects against acute GvHD.
    Cell cycle (Georgetown, Tex.), 2009, Jun-01, Volume: 8, Issue:11

    Topics: Acute Disease; Animals; Cell Cycle; Cell Line; Cyclin-Dependent Kinase 2; Female; Graft vs Host Disease; Mice; Mice, Inbred C57BL; Models, Animal; NF-kappa B; Protein Kinase Inhibitors; Purines; Roscovitine; Signal Transduction; Smad3 Protein; Survival Rate; T-Lymphocytes; Transplantation, Heterologous; Tumor Necrosis Factor-alpha

2009
CDK inhibitors and immune responses.
    Cell cycle (Georgetown, Tex.), 2009, Aug-15, Volume: 8, Issue:16

    Topics: Animals; Cell Line; Cyclin-Dependent Kinases; Female; Graft vs Host Disease; Mice; Models, Animal; Protein Kinase Inhibitors; Purines; Roscovitine; Signal Transduction; T-Lymphocytes

2009